• Meta-Analysis Confirms Targeted Therapy Benefits for Colorectal Cancer Liver Metastases

    A systematic review and meta-analysis evaluated targeted therapy in colorectal cancer liver metastases, examining overall survival, progression-free survival, objective response rate, and conversion to resection. The analysis provides comprehensive evidence on the role of targeted agents in managing liver-limited disease. (Translational Cancer Research)